<DOC>
	<DOC>NCT02948660</DOC>
	<brief_summary>The research contains three parts. Part 1: To explore the evaluating and prognostic values of electroencephalography sleep cycle combined with the serum melatonin and orexin level of patients with disorders of consciousness; Part 2: To assess the efficacy of the wake-promoting function of zolpidem tartrate in comotase patients; Part 3: To assess the efficacy of the wake-promoting function of melatonin in comotase patients.</brief_summary>
	<brief_title>The Role of Sleep-modulating Drugs in the Recovery of Patients With Disorders of Consciousness</brief_title>
	<detailed_description />
	<mesh_term>Consciousness Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Glasgow Coma Scale score &lt;=8 vital signs are stable no history use of sedative or anesthetics premorbid history of developmental, psychiatric, or neurological illness resulting in documented functional disabilities up to time of the injury severe coexisting systemic disease with a limited life expectancy EEG showing nonconvulsive status epilepticus</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>